{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:22:03Z","timestamp":1772929323192,"version":"3.50.1"},"reference-count":45,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2026,2,28]]},"DOI":"10.5582\/bst.2025.01323","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T22:45:56Z","timestamp":1772145956000},"page":"80-90","source":"Crossref","is-referenced-by-count":0,"title":["Predicting non-alcoholic fatty liver disease (NAFLD) using machine learning algorithms: Evidence from a large-scale community cohort in Taiwan"],"prefix":"10.5582","volume":"20","author":[{"given":"Tzu-Chun","family":"Lin","sequence":"first","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ju","family":"Wei","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Cheng","family":"Liang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Chien","family":"Tsai","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hung","family":"Lin","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Hsuan","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"Health Management Center, Department of Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyng-Yuan","family":"Jang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"College of Medicine, Drug Development and Value Creation Research Center, Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Wen","family":"Wang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"College of Medicine, Drug Development and Value Creation Research Center, Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yen","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"Department of Internal Medicine, Gangshan Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zu-Yau","family":"Lin","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"College of Medicine, Drug Development and Value Creation Research Center, Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Lun","family":"Yeh","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"Health Management Center, Department of Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"College of Medicine, Drug Development and Value Creation Research Center, Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee-Fu","family":"Huang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"College of Medicine, Drug Development and Value Creation Research Center, Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Feng","family":"Huang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"College of Medicine, Drug Development and Value Creation Research Center, Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Long","family":"Chuang","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"College of Medicine, Drug Development and Value Creation Research Center, Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Lung","family":"Yu","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"Health Management Center, Department of Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"College of Medicine, Drug Development and Value Creation Research Center, Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Yen","family":"Dai","sequence":"additional","affiliation":[{"name":"Hepatobiliary Division, Department of Internal Medicine, Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"Health Management Center, Department of Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"College of Medicine, Drug Development and Value Creation Research Center, Center for Metabolic Disorders and Obesity, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"Department of Internal Medicine, Gangshan Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"College of Professional Studies, National Pingtung University of Science and Technology, Pingtung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hon-Yi","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Healthcare Administration and Medical Informatics, Kaohsiung Medical University, Kaohsiung, Taiwan."},{"name":"Master of Health Care Management, Department of Business Management, National Sun Yat-sen University, Kaohsiung, Taiwan."},{"name":"Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan."},{"name":"Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Younossi ZM, Golabi P, Paik JM, Henry A, Dongen CV, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review. Hepatology. 2023; 77:1335-1347.","DOI":"10.1097\/HEP.0000000000000004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Le MH, Yeo YH, Zou B, Barnet S, Henry L, Cheung R, Nguyen MH. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach. Clin Mol Hepatol. 2022; 28:841-850.","DOI":"10.3350\/cmh.2022.0239"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Li J, Zou B, Yeo YH, <i>et al<\/i>. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019; 4:389-398.","DOI":"10.1016\/S2468-1253(19)30039-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Le MH, Le DM, Baez TC, Dang H, Nguyen VH, Lee K, Stave CD, Ito T, Wu Y, Yeo YH, Ji F, Cheung R, Nguyen MH. Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Clin Mol Hepatol. 2024; 30:235-246.","DOI":"10.3350\/cmh.2023.0485"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Petroni ML, Brodosi L, Bugianesi E, Marchesini G. Management of non-alcoholic fatty liver disease. BMJ. 2021; 372:m4747.","DOI":"10.1136\/bmj.m4747"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Huang YC, Huang JC, Chien HH, Lin CI, Chuang YS, Cheng HY, Lin WT, Lin YY, Chuang HY, Ho CK, Wang CL, Dai CY. Performance of nonalcoholic fatty liver fibrosis score in estimating atherosclerotic cardiovascular disease risk. Nutr Metab Cardiovasc Dis. 2023; 33:2479-2487.","DOI":"10.1016\/j.numecd.2023.08.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hur MH, Yip TC, Kim SU, <i>et al<\/i>. A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B. J Hepatol. 2025; 82:235-244.","DOI":"10.1016\/j.jhep.2024.11.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, Kleiner DE, Loomba R. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023; 77:1797-1835.","DOI":"10.1097\/HEP.0000000000000323"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Mathew J, Pang CK, Luo M, Leong WH. Classification of Imbalanced Data by Oversampling in Kernel Space of Support Vector Machines. IEEE Trans Neural Netw Learn Syst. 2018; 29:4065-4076.","DOI":"10.1109\/TNNLS.2017.2751612"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Thomson W, Roth AE. The Shapley value: Essays in honor of Lloyd S. Shapley. Economica 1991; 58:123.","DOI":"10.2307\/2554979"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Belle V, Papantonis I. Principles and Practice of Explainable Machine Learning. Front Big Data. 2021; 4:688969.","DOI":"10.3389\/fdata.2021.688969"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hinterreiter A, Ruch P, Stitz H, Ennemoser M, Bernard J, Strobelt H, Streit M. ConfusionFlow: A Model-Agnostic Visualization for Temporal Analysis of Classifier Confusion. IEEE Trans Vis Comput Graph. 2022; 28:1222-1236.","DOI":"10.1109\/TVCG.2020.3012063"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Garnavi R, Aldeen M. Optimized weighted performance index for objective evaluation of border-detection methods in dermoscopy images. IEEE Trans Inf Technol Biomed. 2011; 15:908-917.","DOI":"10.1109\/TITB.2011.2170083"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hamlet P, Tremblay J. Artificial intelligence in medicine. Metabolism 2017;69:S36-S40.","DOI":"10.1016\/j.metabol.2017.01.011"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ahn JC, Connell A, Simonetto DA, Hughes C, Shah VH. Application of Artificial Intelligence for the Diagnosis and Treatment of Liver Diseases. Hepatology. 2021; 73:2546-2563.","DOI":"10.1002\/hep.31603"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Le Berre C, Sandborn WJ, Aridhi S, Devignes MD, Fournier L, Sma\u00efl-Tabbone M, Danese S, Peyrin-Biroulet L. Application of Artificial Intelligence to Gastroenterology and Hepatology. Gastroenterology 2020; 158:76-94.","DOI":"10.1053\/j.gastro.2019.08.058"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Liu P, Fu B, Yang SX, Deng L, Zhong X, Zheng H. Optimizing Survival Analysis of XGBoost for Ties to Predict Disease Progression of Breast Cancer. IEEE Trans Biomed Eng. 2021; 68:148-160.","DOI":"10.1109\/TBME.2020.2993278"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Cao T, Zhu Q, Tong C, Halengbieke A, Ni X, Tang J, Han Y, Li Q, Yang X. Establishment of a machine learning predictive model for non-alcoholic fatty liver disease: A longitudinal cohort study. Nutr Metab Cardiovasc Dis. 2024; 34:1456-1466.","DOI":"10.1016\/j.numecd.2024.02.004"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. McTeer M, Applegate D, Mesenbrink P, <i>et al<\/i>. Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. PLoS One. 2024; 19:e0299487.","DOI":"10.1371\/journal.pone.0299487"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lu MY, Huang CF, Hung CH, <i>et al.<\/i> Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program. Clin Mol Hepatol. 2024; 30:64-79.","DOI":"10.3350\/cmh.2024.0155"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Peng HY, Duan SJ, Pan L, Wang MY, Chen JL, Wang YC, Yao SK. Development and validation of machine learning models for nonalcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2023; 22:615-621.","DOI":"10.1016\/j.hbpd.2023.03.009"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Zheng J, Li J, Zhang Z, Yu Y, Tan J, Liu Y, Gong J, Wang T, Wu X, Guo Z. Clinical Data based XGBoost Algorithm for infection risk prediction of patients with decompensated cirrhosis: A 10-year (2012-2021) Multicenter Retrospective Case-control study. BMC Gastroenterol. 2023; 23:310.","DOI":"10.1186\/s12876-023-02949-3"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Su\u00e1rez M, Mart\u00ednez R, Torres AM, Torres B, Mateo J. A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis. Dig Dis Sci. 2023; 68:3801-3809.","DOI":"10.1007\/s10620-023-08031-y"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Vekariya V, Passi K, Jain CK. Predicting liver cancer on epigenomics data using machine learning. Front Bioinform. 2022; 2:954529.","DOI":"10.3389\/fbinf.2022.954529"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ghandian S, Thapa R, Garikipati A, Barnes G, Green-Saxena A, Calvert J, Mao Q, Das R. Machine learning to predict progression of non-alcoholic fatty liver to non-alcoholic steatohepatitis or fibrosis. JGH Open. 2022; 6:196-204.","DOI":"10.1002\/jgh3.12716"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Liu YX, Liu X, Cen C, Li X, Liu JM, Ming ZY, Yu SF, Tang XF, Zhou L, Yu J, Huang KJ, Zheng SS. Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study. Hepatobiliary Pancreat Dis Int. 2021; 20:409-415.","DOI":"10.1016\/j.hbpd.2021.08.004"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Agarwal S, Sharma S, Kumar M, Venishetty S, Bhardwaj A, Kaushal K, Gopi S, Mohta S, Gunjan D, Saraya A, Sarin SK. Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease: A proof of concept. J Gastroenterol Hepatol. 2021; 36:2935-2942.","DOI":"10.1111\/jgh.15560"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. de Alwis NMW, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008; 48:S104-S112.","DOI":"10.1016\/j.jhep.2008.01.009"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Martin A, Lang S, Goeser T, Demir M, Steffen HM, Kasper P. Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease. Curr Atheroscler Rep. 2022; 24:533-546.","DOI":"10.1007\/s11883-022-01028-4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Deprince A, Haas JT, Staels B. Dysregulated lipid metabolism links NAFLD to cardiovascular disease. Mol Metab. 2020; 42:101092.","DOI":"10.1016\/j.molmet.2020.101092"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Chatrath H, Vuppalanchi R, Chalasani N. Dyslipidemia in patients with nonalcoholic fatty liver disease. Semin Liver Dis. 2012; 32:22-29.","DOI":"10.1055\/s-0032-1306423"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Sun DQ, Liu WY, Wu SJ, Zhu GQ, Braddock M, Zhang DC, Shi KQ, Song D, Zheng MH. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease. Oncotarget. 2016; 7:5728-5737.","DOI":"10.18632\/oncotarget.6799"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Tomizawa M, Kawanabe Y, Shinozaki F, Sato S, Motoyoshi Y, Sugiyama T, Yamamoto S, Sueishi M. Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes. Biomed Rep. 2014; 2:633-636.","DOI":"10.3892\/br.2014.309"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016; 17:510-519.","DOI":"10.1111\/obr.12407"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Pang Q, Zhang JY, Song SD, Qu K, Xu XS, Liu SS, Liu C. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J Gastroenterol. 2015; 21:1650-1662.","DOI":"10.3748\/wjg.v21.i5.1650"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Zou Y, Yu M, Sheng G. Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study. Lipids Health Dis 2020; 19:145.","DOI":"10.1186\/s12944-020-01326-3"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Alnimer Y, Alnimer T. Prediction of Liver Steatosis and Fibrosis Based on Clinical Variables Using a Large National Survey Database. Can J Gastroenterol Hepatol. 2023; 1791500.","DOI":"10.1155\/2023\/1791500"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Wang G, Shen X, Wang Y, Lu H, He H, Wang X. Analysis of risk factors related to nonalcoholic fatty liver disease: a retrospective study based on 31,718 adult Chinese individuals. Front Med. 2023; 10:1168499.","DOI":"10.3389\/fmed.2023.1168499"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Noureddin M, Ntanios F, Malhotra D, Hoover K, Emir B, McLeod E, Alkhouri N. Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learning. Hepatol Commun. 2022; 6:1537-1548.","DOI":"10.1002\/hep4.1935"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Huang JF, Tsai PC, Yeh ML, Huang CF, Huang CI, Hsieh MH, Dai CY, Yang JF, Chen SC, Yu ML, Chuang WL, Chang WY. Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. J Formos Med Assoc. 2020; 119:89-96.","DOI":"10.1016\/j.jfma.2019.03.014"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Chen YY, Lin CY, Yen HH, Su PY, Zeng YH, Huang SP, Liu IL. Machine-Learning Algorithm for Predicting Fatty Liver Disease in a Taiwanese Population. J Pers Med. 2022; 12:1026.42.","DOI":"10.3390\/jpm12071026"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Long MT, Pedley A, Massaro JM, Hoffmann U, Ma J, Loomba R, Chung RT, Benjamin EJ. A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study. Liver Int. 2018; 38:1495-1503.","DOI":"10.1111\/liv.13709"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Li L, Liu DW, Yan HY, Wang ZY, Zhao SH, Wang B. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016; 17:510-519.","DOI":"10.1111\/obr.12407"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Eguchi Y, Hyogo H, Ono M, Mizuta T, Ono N, Fujimoto K, Chayama K, Saibara T; JSG-NAFLD. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: A multicenter large retrospective study. J Gastroenterol. 2012; 47:586-595.","DOI":"10.1007\/s00535-012-0533-z"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Hagstr\u00f6m H, Vessby J, Ekstedt M, Shang Y. 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J Hepatol. 2024; 80:e76-e77.","DOI":"10.1016\/j.jhep.2023.08.026"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/20\/1\/20_2025.01323\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:59:16Z","timestamp":1772859556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/20\/1\/20_2025.01323\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2025.01323","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"article-number":"2025.01323"}}